100 related articles for article (PubMed ID: 7427955)
1. A phase II study of fluorodopan in the treatment of advanced colorectal cancer.
Nair KG; Moayeri H; Mittelman A
Cancer Treat Rep; 1980; 64(4-5):697-99. PubMed ID: 7427955
[TBL] [Abstract][Full Text] [Related]
2. Phase II study of chlorozotocin in the treatment of advanced colorectal cancer.
Lawton JO; Giles GR; Hall J; MacAdam A; Hall R; Matheson T; Bird G
Cancer Treat Rep; 1981; 65(1-2):13-15. PubMed ID: 6452945
[TBL] [Abstract][Full Text] [Related]
3. CBDCA: phase II evaluation in advanced colorectal carcinoma.
Pazdur R; Samson MK; Baker LH
Am J Clin Oncol; 1987 Apr; 10(2):136-8. PubMed ID: 3551576
[TBL] [Abstract][Full Text] [Related]
4. Phase II evaluation of metoprine with leucovorin rescue in patients with advanced colorectal carcinoma.
Lynch G; Currie V; Kemeny N
Cancer Clin Trials; 1981; 4(3):281-3. PubMed ID: 6974612
[TBL] [Abstract][Full Text] [Related]
5. Phase II trial of iv 6-thioguanine in advanced colorectal carcinoma.
Britell JC; Moertel CG; Kvols LK; O'Connell MJ; Rubin J; Schutt AJ
Cancer Treat Rep; 1981; 65(9-10):909-10. PubMed ID: 7273027
[TBL] [Abstract][Full Text] [Related]
6. Phase II evaluation of DON (6-diazo-5-oxo-L-norleucine) in patients with advanced colorectal carcinoma.
Lynch G; Kemeny N; Casper E
Am J Clin Oncol; 1982 Oct; 5(5):541-3. PubMed ID: 7180833
[TBL] [Abstract][Full Text] [Related]
7. Phase II study of 3-deazauridine in advanced colorectal adenocarcinoma.
Bruno S; Creaven PJ; Ledesma E; Poster D; Yoon J; Mittelman A
Am J Clin Oncol; 1982 Feb; 5(1):69-71. PubMed ID: 7081140
[TBL] [Abstract][Full Text] [Related]
8. Phase I-II trial of methyl-GAG in advanced colon cancer. a Southwest Oncology Group pilot study.
Myers JW; Knight WA; Livingston RB; Fabian C; Costanzi J
Cancer Clin Trials; 1981; 4(3):277-9. PubMed ID: 7285275
[TBL] [Abstract][Full Text] [Related]
9. Phase II evaluation of 4'-epi-doxorubicin in patients with advanced colorectal carcinoma.
Michaelson R; Kemeny N; Young C
Cancer Treat Rep; 1982 Sep; 66(9):1757-8. PubMed ID: 6956441
[TBL] [Abstract][Full Text] [Related]
10. Phase II study of metronidazole therapy for advanced colorectal carcinoma.
Frytak S; Moertel CG; Childs DS; Schutt AJ; Albers JW
Cancer Treat Rep; 1978 Mar; 62(3):483-5. PubMed ID: 348320
[TBL] [Abstract][Full Text] [Related]
11. Phase II study of dibromodulcitol in colorectal, kidney, and other carcinomas.
Mischler NE; Tormey DC; Klotz J; Borden EC; Ramirez G; Banerjee TK; Carr RM; Zaentz SD; Graf J
Cancer Clin Trials; 1981; 4(4):407-10. PubMed ID: 7318122
[TBL] [Abstract][Full Text] [Related]
12. Phase II study of N-methylformamide in patients with advanced colorectal cancer.
Tchekmedyian NS; Kaplan RS; Eisenberger M; Abrams J; Van Echo D
Cancer Treat Rep; 1987 May; 71(5):541-2. PubMed ID: 3567980
[No Abstract] [Full Text] [Related]
13. Phase II evaluation of metoprine in patients with advanced colorectal carcinoma.
Lynch G; Kemeny N; Currie V
Cancer Treat Rep; 1981; 65(1-2):127-8. PubMed ID: 7226162
[No Abstract] [Full Text] [Related]
14. [Phase II study of THP patients with gastrointestinal cancer].
Niimoto M; Yoshinaka K; Hattori T; Kobayashi S; Hada Y; Hosoma S; Hatayama T; Ogawa Y; Iwamori S; Nagata N
Gan To Kagaku Ryoho; 1986 Feb; 13(2):362-7. PubMed ID: 3947111
[TBL] [Abstract][Full Text] [Related]
15. [A phase II study of ranomustine (MCNU) tablets in patients with gastrointestinal cancer--by cooperative study group].
Taguchi T
Gan To Kagaku Ryoho; 1984 Nov; 11(11):2420-6. PubMed ID: 6497400
[TBL] [Abstract][Full Text] [Related]
16. Phase II trial of bisantrene in advanced colorectal cancer: a cancer and leukemia group B study.
Perry MC; Forastiere AA; Richards F; Weiss RB; Anbar D
Cancer Treat Rep; 1982 Nov; 66(11):1997-8. PubMed ID: 7139643
[No Abstract] [Full Text] [Related]
17. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M;
Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206
[TBL] [Abstract][Full Text] [Related]
18. Eastern Cooperative Oncology Group phase II studies in advanced measurable colorectal cancer. I. Razoxane, Yoshi-864, piperazinedione, and lomustine.
Douglass HO; MacIntyre JM; Kaufman J; Von Hoff D; Engstrom PF; Klaassen D
Cancer Treat Rep; 1985 May; 69(5):543-5. PubMed ID: 2988774
[TBL] [Abstract][Full Text] [Related]
19. [Phase II study on MCNU in patients with advanced or recurrent gastrointestinal cancer].
Niimoto M; Yoshinaka K; Hattori T; Kobayashi S; Hosoma S; Ogawa Y; Iwamori S; Nagata N; Yamagata S; Nishimawari K
Gan To Kagaku Ryoho; 1985 Sep; 12(9):1813-9. PubMed ID: 4037810
[TBL] [Abstract][Full Text] [Related]
20. Oral estramustine phosphate (Estracyt): a broad phase II study.
Halpern J; Catane R
J Med; 1984; 15(1):35-43. PubMed ID: 6593404
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]